Biological Safety Testing Market | Growth, Trends, and Forecast (2019-2024)

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Biological Safety Testing Market_Image 1

Study Period:

2016-2024

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The biological safety testing market is expected witness a CAGR of 12.4% during the forecast period. Factors that are driving the market growth include growth in the pharmaceutical and biotechnology industries, along with increasing investments, and rising production of new biologics due to high disease burden.

The biotechnology-derived products or biologicals have effectively made their ways into various aspects of healthcare, including diagnoses, prevention, and treatments of diseases.
However, there remain certain potential safety concerns, which generally arise from the manufacturing processes and complex biological and structural characteristics of these products.
Therefore, such products require detailed and systematic biological safety testing, which eventually enables the adequate assessment of safety, before any kind of clinical investigation.
Hence, the market is expected to observe significant growth, globally, over the forecast period.

Scope of the Report

Biological safety testing refers to the testing procedures that are carried out to ensure non-contamination of biopharmaceuticals and vaccines and to comply with regulations regarding the same. This includes various types of sterility tests, cell line authentication and characterization tests, bioburden tests, endotoxin tests, adventitious agent detection tests, and residual host contamination detection tests, among others.

Product
		Reagents and Kits
		Instruments
		Other Products

Application
		Vaccines and Therapeutics
		Cellular and Gene Therapy
		Blood and Blood-based Therapy
		Other Applications

Test
		Sterility Tests
		Cell Line Authentication and Characterisation Tests
		Bioburden Tests
		Endotoxin Tests
		Adventitious Agent Detection Tests
		Other Tests

Geography

North America
	US
	Canada
	Mexico

Europe
	Germany
	UK
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccines and Therapeutics Segment is Expected to Hold Significant Share in the Application Segment of the Market

Vaccination is considered the most effective way of preventing infection and severe outcomes caused by a number of deadly viruses. Every licensed and recommended vaccine has to go through years of safety testing, including the testing and evaluation of the vaccine, before it is licensed by the Food and Drug Administration (FDA) and recommended for use by the Centers for Disease Control and Prevention (CDC). Safety testing also includes monitoring the vaccine’s safety after it is recommended for infants, children, or adults. The vaccine continues to be tested, even after it receives approval. The company that manufactures the vaccine continues to test several batches, in order to make sure that the vaccine is potent, pure, and sterile.

Biological Safety Testing Market_Image 2

To understand key trends, Download Sample Report

North America Dominates the Market and is Expected to do the Same in the Forecast Period

The growth of the biological safety testing market in North America can be directly attributed to the growing biotechnology and pharmaceutical industries in the region. The high growth of these industries is further attributable to factors, such as innovative technologies and the presence of favorable government initiatives. Additionally, the advanced healthcare infrastructure and rising R&D spending is expected to increase the revenue size further.

Biological Safety Testing Market_Image 3

To understand geography trends, Download Sample Report.

Competitive Landscape

The biological safety testing market is highly competitive and consists of a few major players. Companies, like Avance Biosciences, Cytovance Biologics, Eurofins Scientific, Lonza, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Toxikon, and WuXi AppTec, among others, hold a substantial share in the market.

Major Players

Biological Safety Testing Market_Image 4

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Growth in the Pharmaceutical and Biotechnology Industries, along with Increasing Investments
  2. 4.2.2 Rising Production of New Biologics due to High Disease Burden
3. 4.3 Market Restraints
  1. 4.3.1 Time Consuming Approval Process
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 Product
  1. 5.1.1 Reagents and Kits
  2. 5.1.2 Instruments
  3. 5.1.3 Other Products
2. 5.2 Application
  1. 5.2.1 Vaccines and Therapeutics
  2. 5.2.2 Cellular and Gene Therapy
  3. 5.2.3 Blood and Blood-based Therapy
  4. 5.2.4 Other Applications
3. 5.3 Test
  1. 5.3.1 Sterility Tests
  2. 5.3.2 Cell Line Authentication and Characterisation Tests
  3. 5.3.3 Bioburden Tests
  4. 5.3.4 Endotoxin Tests
  5. 5.3.5 Adventitious Agent Detection Tests
  6. 5.3.6 Other Tests
4. 5.4 Geography
  1. 5.4.1 North America
    1. 5.4.1.1 US
    2. 5.4.1.2 Canada
    3. 5.4.1.3 Mexico
  2. 5.4.2 Europe
    1. 5.4.2.1 Germany
    2. 5.4.2.2 UK
    3. 5.4.2.3 France
    4. 5.4.2.4 Italy
    5. 5.4.2.5 Spain
    6. 5.4.2.6 Rest of Europe
  3. 5.4.3 Asia-Pacific
    1. 5.4.3.1 China
    2. 5.4.3.2 Japan
    3. 5.4.3.3 India
    4. 5.4.3.4 Australia
    5. 5.4.3.5 South Korea
    6. 5.4.3.6 Rest of Asia-Pacific
  4. 5.4.4 Middle East & Africa
    1. 5.4.4.1 GCC
    2. 5.4.4.2 South Africa
    3. 5.4.4.3 Rest of Middle East & Africa
  5. 5.4.5 South America
    1. 5.4.5.1 Brazil
    2. 5.4.5.2 Argentina
    3. 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Avance Biosciences
  2. 6.1.2 Cytovance Biologics
  3. 6.1.3 Eurofins Scientific
  4. 6.1.4 Lonza
  5. 6.1.5 Merck KGaA
  6. 6.1.6 Promega Corporation
  7. 6.1.7 Thermo Fisher Scientific
  8. 6.1.8 Toxikon
  9. 6.1.9 WuXi AppTec
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

* List Not Exhaustive

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

Biological Safety Testing Market - Growth, Trends, and Forecast (2020 - 2025)

Market Snapshot

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Scope of the Report

Key Market Trends

Vaccines and Therapeutics Segment is Expected to Hold Significant Share in the Application Segment of the Market

North America Dominates the Market and is Expected to do the Same in the Forecast Period

Competitive Landscape

Major Players

Table Of Contents

Related Reports

LINKS

CONTACT

JOIN US